Brief: Theradiag H1 Revenue Up At 6.3 Million Euros

Theradiag SA

18/07/2022 06:37

July 18 (Reuters) - Theradiag SA  ALTHE.PA :
    * REPORTS REVENUE OF EUR 6.3 MILLION FOR FIRST HALF OF 2022,
UP
14.3%
    * CASH POSITION OF EUR 6.0 MILLION ON JUNE 30, 2022, IN LINE
WITH
BUDGET
    * STRONG GROWTH OF 19.3% IN IVD (IN VITRO DIAGNOSTICS)
ACTIVITY IN
H1
    * SOLID GROWTH OF 9.3% FOR THERANOSTICS IN H1
    * IN SECOND HALF OF 2022, WE WILL STRIVE TO CONTINUE
IMPLEMENTING
OUR STRATEGIC PLAN THAT WILL ALLOW US TO IMPROVE ALL OUR
FINANCIAL INDICATORS-CEO
    * COMPANY IS IN A PERIOD OF REFLECTION IN ORDER TO OPTIMIZE
ITS
COMMERCIAL ACTIVITIES ON NORTH AMERICAN MARKET.
    * OUTLOOK: WILL REMAIN AGILE BY SEIZING ANY OPPORTUNITIES
THAT
ARISE ON IVD MARKET - CHAIMAN BOD

Source text for Eikon:  ID:nBw2DWFVPa 
Further company coverage:  ALTHE.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))